Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
- Nancy L. Bartlett
- , Sarit Assouline
- , Pratyush Giri
- , Stephen J. Schuster
- , Chan Y. Cheah
- , Matthew Matasar
- , Gareth P. Gregory
- , Dok Hyun Yoon
- , Mazyar Shadman
- , Keith Fay
- , Sung Soo Yoon
- , Carlos Panizo
- , Ian Flinn
- , Anna Johnston
- , Francesc Bosch
- , Laurie H. Sehn
- , Michael C. Wei
- , Shen Yin
- , Iris To
- , Chi Chung Li
Research output: Contribution to journal › Article › peer-review
85
Link opens in a new tab
Citations
(Scopus)